HTG Molecular Diagnostics, Inc. Deferred Offering Costs
HTG Molecular Diagnostics, Inc. had Deferred Offering Costs of $0 as of 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2021-03-25
- 2020-12-31: Deferred Offering Costs $0.00.
- 2019-12-31: Deferred Offering Costs $100.00K; Deferred Offering Costs as first filed $140.32K.
- 2018-12-31: Deferred Offering Costs $59.03K.
- 2017-12-31: Deferred Offering Costs $2.95K.
| Period end | Deferred Offering Costs | Deferred Offering Costs as first filed |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-25 | |
| 2019-12-31 | $100.00K 10-K · filed 2021-03-25 | $140.32K 10-K · filed 2020-03-25 |
| 2018-12-31 | $59.03K 10-K · filed 2020-03-25 | |
| 2017-12-31 | $2.95K 10-K · filed 2019-03-07 | |
| 2016-12-31 | $49.63K 10-K · filed 2018-03-23 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-23 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $1.60M 10-Q · filed 2015-06-08 | |
| 2014-12-31 | $1.30M 10-K · filed 2016-03-25 |